← All tickers

Is OGN Worth Buying in 2026?

Organon & Co.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Organon & Co. (OGN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.28% over 10 days); RSI 44 — healthy momentum range; strong 1-year return of +34.3%; 3-month momentum positive (+20.1%). Currently 0.6% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

OGN is in a confirmed uptrend, trading above both its 50-day ($13.45) and 200-day ($9.46) moving averages. An RSI of 44.1 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +34.3% compares to +16.5% for SPY (beat the market by 17.8%).

$10,000 invested 1 year ago → $13,426 today
vs. S&P 500 (SPY) — same period beat market by 17.8%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($9.46)
✓Above 50-day MA ($13.45)
✓RSI(14) neutral zone (30–70) — currently 44.1
✓Positive return (+34.3%)
✓Within 10% of period high (−0.6%)
Period Range $13.52
$5.69 $13.60
RSI (14) 44.1
0 · OversoldOverbought · 100

Key Metrics

Price$13.52
Period Return+34.3%
Period High$13.60
Period Low$5.69
Drawdown−0.6%
MA-50$13.45
MA-200$9.46
RSI (14)44.1
Avg Volume (30d)2.6M
vs. SPYbeat by 17.8%
Return Rank#281 of 999

Trade OGN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers